Vivos Therapeutics, Inc. · NASDAQ:VVOS

Streeterville Capital LLC reported a 9.30% stake in Vivos Therapeutics, Inc. (Schedule 13G)

Event Aug 11, 2026 · Filed Aug 11, 2026

Streeterville Capital LLC reported a 9.30% stake in Vivos Therapeutics, Inc., 1,812,031 shares, as a passive investor on Aug 11, 2026. Filed Aug 11, 2026 (Schedule 13G).

Stake
9.30%
Shares
1,812,031
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Streeterville Capital LLC9.30%1,812,031
Streeterville Management, LLC9.30%1,812,031
John M Fife9.30%1,812,031

Source

View original at SEC

Related